Current Medications That May Slow Cognitive Decline

Several medications have been shown to slow the rate of memory loss and thinking problems in people with Alzheimer's disease, though none reverse the damage already done. The oldest class, called cholinesterase inhibitors, includes donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne). These work by preserving a chemical in the brain that helps nerve cells communicate. They are most commonly prescribed in the early and middle stages of the disease.

A newer medication called memantine (Namenda) works differently — it regulates another brain chemical called glutamate. Memantine is often used in moderate to advanced stages, and doctors sometimes prescribe it alongside a cholinesterase inhibitor. Both types of medication may reduce the speed of decline by several months, though the effect varies widely from person to person.

In 2023, the FDA approved lecanemab (Leqembi), an infusion medication that targets amyloid, a protein that builds up in Alzheimer's brains. This drug is given intravenously every two weeks and is intended for people in the early stages of cognitive decline. It requires regular brain imaging to monitor for a side effect called amyloid-related imaging abnormalities (ARIA), and it is not suitable for everyone — your doctor will order specific tests before recommending it.

Key Takeaways

  • Cholinesterase inhibitors and memantine are oral medications that may slow cognitive decline by several months, with effects varying by individual.
  • Lecanemab is an infusion given every two weeks for people in early cognitive decline and requires regular brain imaging to monitor for side effects.
  • Medications work best when started early and combined with cognitive activities, physical exercise, and management of other health conditions like high blood pressure and diabetes.
  • Your doctor will order blood tests and imaging before prescribing any Alzheimer's medication to rule out other causes of memory loss and assess your overall health.
  • Managing depression, sleep problems, and behavioral changes often requires separate medications and may improve quality of life more than cognitive medications alone.

Non-Medication Approaches That Support Brain Health

Research shows that physical exercise, cognitive stimulation, and social engagement may slow cognitive decline or delay symptoms. Regular aerobic activity — walking, swimming, or cycling — appears to have measurable effects on brain structure and memory. Cognitive activities like puzzles, reading, learning new skills, or playing games engage the brain in ways that may build mental reserve.

Sleep quality matters significantly. People with untreated sleep apnea or poor sleep patterns show faster cognitive decline. If a person with Alzheimer's has daytime sleepiness, loud snoring, or pauses in breathing, a sleep study may reveal a treatable condition. Similarly, managing high blood pressure, diabetes, and high cholesterol reduces the risk of further cognitive decline, since these conditions damage blood vessels in the brain.

Social connection and purposeful activity — volunteering, spending time with family, attending classes or clubs — are associated with slower decline. A structured daily routine that includes these elements, combined with adequate nutrition and management of hearing and vision problems, creates the best environment for maintaining cognitive function as long as possible.

Managing Behavioral and Psychological Symptoms

As Alzheimer's progresses, people often experience depression, anxiety, agitation, wandering, or aggression. These symptoms are not character flaws and are not always best treated with medication. Before prescribing psychiatric drugs, doctors should investigate the cause: pain, constipation, urinary tract infection, medication side effects, or environmental triggers like noise or overstimulation can all trigger behavioral changes.

When medication is needed, antidepressants are often tried first for depression and anxiety. Antipsychotic medications carry risks in older adults — they increase the risk of stroke and death in people with dementia — and are reserved for severe agitation or hallucinations that do not respond to other approaches. Behavioral strategies, such as redirecting attention, simplifying the environment, and maintaining a calm routine, often work as well as or better than medication.

A geriatric psychiatrist or behavioral neurologist can help distinguish between symptoms that need medication and those that respond better to environmental changes or caregiver training. Many communities offer caregiver support groups and training programs that teach techniques for managing difficult behaviors without medication.

How to Work With Your Doctor on Treatment Decisions

Before starting any Alzheimer's medication, your doctor should order blood tests to rule out other causes of memory loss — vitamin B12 deficiency, thyroid disease, and depression can all mimic Alzheimer's symptoms and are treatable. Imaging (usually an MRI or CT scan) may be ordered to rule out stroke or tumor. If you have had a recent diagnosis, ask whether cognitive testing (neuropsychological testing) has been done to confirm the type and stage of cognitive decline.

Discuss with your doctor what you hope medication will achieve. Some people want to slow decline as much as possible; others prioritize quality of life and prefer to avoid frequent infusions or brain imaging. Your age, other health conditions, current medications, and stage of disease all affect which treatments make sense. If a medication causes side effects, tell your doctor before stopping it — the dose may be adjusted or a different medication tried.

Keep a record of which medications you have tried, at what doses, and what effects you noticed. This information is valuable if you see a specialist or change doctors. Ask your pharmacist to review all your medications together, since some Alzheimer's drugs interact with common blood pressure or heart medications.

Clinical Trials and Emerging Treatments

Dozens of experimental Alzheimer's treatments are in clinical trials at any given time. These trials test new medications, combinations of existing drugs, and approaches targeting different aspects of the disease. If standard treatments have not worked or if you are interested in contributing to research, ask your doctor whether you might be a candidate for a trial.

The Alzheimer's Association maintains a searchable database of trials at alz.org/research/clinical-trials. Trials vary widely in what they require — some involve frequent visits and testing, others are conducted by phone or mail. Participation is voluntary and you can withdraw at any time. Trials do not always lead to a new approved medication, but they provide access to experimental treatments and close medical monitoring.

Cost and Insurance Coverage

Cholinesterase inhibitors and memantine are generic or low-cost brand medications and are usually covered by Medicare Part D (prescription drug coverage) and most insurance plans, though you may pay a copay. Lecanemab is expensive — the list price is several thousand dollars per infusion — and coverage varies. Medicare covers it for people with mild cognitive impairment or mild dementia due to Alzheimer's disease, but you will need to meet specific criteria and your doctor will need to document them.

If cost is a barrier, ask your doctor about patient information programs run by manufacturers, or contact your state pharmaceutical information program. The Eldercare Locator (1-800-677-1116) can direct you to local resources that help with medication costs. Some clinical trials cover the cost of experimental drugs and related medical care for participants.

Frequently Asked Questions

Can Alzheimer's medications stop the disease or reverse memory loss?

No. Current medications slow the rate of decline by several months on average, but they do not stop the disease or restore lost memory. The goal is to maintain function and independence as long as possible, not to cure the disease.

At what stage of Alzheimer's should treatment start?

Cholinesterase inhibitors work best in early and middle stages. Lecanemab is designed for early cognitive decline, before a full Alzheimer's diagnosis. Memantine is often started in moderate to advanced stages. Your doctor will recommend timing based on your test results and stage of disease.

What happens if a medication stops working or causes side effects?

Tell your doctor before stopping any medication. The dose may be adjusted, or a different medication tried. Some people respond better to one drug than another, so switching is common and reasonable. Your doctor may also recommend adding a non-medication approach or addressing a separate condition like depression or sleep problems.

Is lecanemab right for everyone with Alzheimer's?

No. Lecanemab is for people in early stages of cognitive decline and requires regular brain imaging. It is not suitable if you have certain genetic factors, bleeding disorders, or conditions that make imaging risky. Your doctor will order tests to determine whether it is an option for you.

Do I need to see a specialist, or can my regular doctor manage Alzheimer's treatment?

Many primary care doctors manage Alzheimer's medications successfully. A neurologist or geriatrician may be helpful if diagnosis is unclear, if you have complex medical conditions, or if standard treatments are not working well. Ask your doctor whether a specialist referral would be useful in your situation.